en

PRODUCT DETAIL

Pemazyre 13,5 mg tablety

Code 7349D
MA number EU/1/21/1535/005
Product Form: tbl 14x13,5 mg (blis.PVC/Al)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
L01EN02 Pemigatinib
Shelf life: 48
Container: blister PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 26.03.2021
Validity: 29.03.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 29.02.2024
eu-flag.png sk-flag.png